Form 4 for EQH Equitable Holdings, Inc.
Accepted 2024-04-16 00:00:00 ET · period of report 2024-04-15 · accession 0000950170-24-044843 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-04-16 | 2024-04-15 | EQH | Pearson Mark | Pres, CEO, Dir | S - Sale+OE | $36.24 | -30.0K | 699.2K | -4% | -$1.09M |
| DT | 2024-04-16 | 2024-04-15 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $21.34 | +20.0K | 715.0K | +3% | +$426.8K |
| DT | 2024-04-16 | 2024-04-15 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $0.00 | -20.0K | 566.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-15 | S | D | 1,954 | $36.93 | 685,025.48 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $36.7300 to $37.1800. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 2 | Common | Common Stock | 2024-04-15 | M | A | 20,000 | $21.34 | 715,025.48 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F2) Includes Restricted Stock Units. |
| 3 | Common | Common Stock | 2024-04-15 | S | D | 4,200 | $36.91 | 695,025.48 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F4) This transaction was executed in multiple trades at prices ranging from $36.6800 to $37.2200. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 4 | Common | Common Stock | 2024-04-15 | S | D | 8,046 | $36.07 | 686,979.48 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F5) This transaction was executed in multiple trades at prices ranging from $35.6900 to $36.6800. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 5 | Common | Common Stock | 2024-04-15 | S | D | 15,800 | $36.06 | 699,225.48 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F3) This transaction was executed in multiple trades at prices ranging from $35.6800 to $36.6700. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2024-04-15 | M | D | 20,000 | $0.00 | 566,400 | D | $21.34 · — to 2028-03-01 | 20,000 Common Stock | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F7) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vest/vested in three installments beginning on March 1, 2019. |